<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We have followed prospectively, 46 <z:mp ids='MP_0001261'>obese</z:mp>, type 2 diabetic patients for a 55-week period, in order to evaluate the efficiency of an educational programme based on behaviour modification to enhance <z:hpo ids='HP_0001824'>weight loss</z:hpo> and changes of other <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factors</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>No patient received pharmacological treatment during the study </plain></SENT>
<SENT sid="2" pm="."><plain>At the end of the follow-up the patients obtained an average <z:hpo ids='HP_0001824'>weight loss</z:hpo> of 9.250 kg (range: 0.500-17.500 kg); the BMI was reduced from 34.2 +/- 0.8 kg/m2 to 30.6 +/- 1.1 kg/m2 (P less than 0.01); fasting serum <z:chebi fb="105" ids="17234">glucose</z:chebi> descended from 7.9 +/- 0.4 to 6.1 +/- 0.5 mM (P less than 0.05); SBP (systolic blood pressure) decreased from 145.7 +/- 3 to 126.4 +/- 5.1 mmHg (P less than 0.01); <z:chebi fb="4" ids="35861">DBP</z:chebi> (diastolic blood pressure) decreased from 83.5 +/- 2.5 to 65 +/- 2.6 mmHg (P less than 0.01); <z:chebi fb="0" ids="17855">triglyceride</z:chebi> levels were lowered from 164.5 +/- 12 to 109.7 +/- 10 mg/dl (P less than 0.01); <z:chebi fb="4" ids="47775">HDL-cholesterol</z:chebi> levels increased from 1.27 +/- 0.05 to 1.53 +/- 0.12 mM (P less than 0.01) </plain></SENT>
<SENT sid="3" pm="."><plain>Serum <z:chebi fb="105" ids="17234">glucose</z:chebi> 2 h after a 75 g <z:chebi fb="105" ids="17234">glucose</z:chebi> oral load decreased from 14.9 +/- 0.6 to 12.7 +/- 0.9 mM (P less than 0.05) on week 35 of follow-up </plain></SENT>
<SENT sid="4" pm="."><plain>Twelve patients no longer presented a diabetic curve (8 <z:mpath ids='MPATH_458'>normal</z:mpath> oral <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance test (OGTT) curves, and 4 <z:hpo ids='HP_0000833'>impaired glucose tolerance</z:hpo> (IGT) curves) </plain></SENT>
<SENT sid="5" pm="."><plain>No significant changes in the parameters studied were obtained in the group of patients on conventional treatment.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>